Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-119818
Filing Date
2026-03-23
Accepted
2026-03-23 16:30:03
Documents
90
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K srzn-20251231.htm   iXBRL 10-K 3399832
2 EX-10.7 srzn-ex10_7.htm EX-10.7 126667
3 EX-10.8 srzn-ex10_8.htm EX-10.8 201633
4 EX-23.1 srzn-ex23_1.htm EX-23.1 10362
5 EX-31.1 srzn-ex31_1.htm EX-31.1 17510
6 EX-31.2 srzn-ex31_2.htm EX-31.2 17755
7 EX-32.1 srzn-ex32_1.htm EX-32.1 9737
8 EX-32.2 srzn-ex32_2.htm EX-32.2 10926
9 GRAPHIC img18949229_0.jpg GRAPHIC 108897
10 GRAPHIC img18949229_1.jpg GRAPHIC 112187
11 GRAPHIC img18949229_2.jpg GRAPHIC 77372
12 GRAPHIC img18949229_3.jpg GRAPHIC 60455
13 GRAPHIC img18949229_4.jpg GRAPHIC 74753
14 GRAPHIC img18949229_5.jpg GRAPHIC 112187
  Complete submission text file 0001193125-26-119818.txt   15086911

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT srzn-20251231.xsd EX-101.SCH 1875859
94 EXTRACTED XBRL INSTANCE DOCUMENT srzn-20251231_htm.xml XML 2508572
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

EIN.: 301374889 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39635 | Film No.: 26782629
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)